Page last updated: 2024-08-18

pyrroles and formononetin

pyrroles has been researched along with formononetin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, C; Li, G; Liu, FK; Liu, JY; Shen, L; Wu, GN; Wu, XY; Wu, ZF; Xu, H; Yao, XQ	1

Other Studies

1 other study(ies) available for pyrroles and formononetin

Article	Year
Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Oncotarget, 2015, Dec-29, Volume: 6, Issue:42 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Aorta; Breast Neoplasms; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Female; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Isoflavones; Male; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 2; Signal Transduction; STAT3 Transcription Factor; Sunitinib; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2015

Article

Year

Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.

Oncotarget, 2015, Dec-29, Volume: 6, Issue:42

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Aorta; Breast Neoplasms; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Female; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Isoflavones; Male; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 2; Signal Transduction; STAT3 Transcription Factor; Sunitinib; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2015